Article
Hepatitis C Virus E2 Envelope Glycoprotein Induces an Immunoregulatory Phenotype in Macrophages.
Hepatology (Baltimore, Md.) - 1 May 2019
Kwon Young-Chan, Meyer Keith, Peng Guangyong, Chatterjee Soumya, Hoft Daniel F, Ray Ranjit
Abstract excerpt
A comprehensive strategy to control hepatitis C virus (HCV) infection needs a vaccine. Our phase I study with recombinant HCV E1/E2 envelope glycoprotein (EnvGPs) as a candidate vaccine did not induce a strong immune response in volunteers. We analyzed the interactions of HCV EnvGPs with human monocyte-derived macrophages as antigen-presenting cells. HCV E2 induced immune regulatory cytokine interleukin (IL)-10...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
